Xiling Shen

Xiling Shen is a High Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on oncology, cancer biology, and immunology, with a particular emphasis on colorectal cancer (CRC), tumor biology, and cell biology. His recent work includes pioneering studies on cancer evolution profiling and interception through the ASCEND-CRC program, as well as investigations into aspirin use and PI3K mutations in metastatic CRC. He has also contributed to advancing transplant medicine through continuous multiparametric monitoring of donor livers during normothermic perfusion and developing rapid point-of-care cytokine monitoring assays. His latest publications appear in leading journals including Cancer Cell, the Journal of Clinical Oncology, and ACS Sensors, reflecting his translational approach to cancer care and medicinal research.